82.41
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Disc Medicine Inc Borsa (IRON) Ultime notizie
Will FDA Bitopertin Rejection and New Legal Probe Change Disc Medicine's (IRON) Narrative? - Sahm
Disc (IRON) Quarterly Figures: EPS Exceeds Its Estimate for the Current Session; Price Reaction: Shares Move 1.84% Lower in the Available RecordQuarterly Earnings - vinanet.vn
Rosen Law Firm investigates Disc Medicine over potential securities claims - scanx.trade
Handelsbanken Fonder AB Buys Shares of 12,700 Disc Medicine, Inc. $IRON - MarketBeat
Disc (IRON) Q2 2026 Results: The Bottom-Line Figure Outpaces Its Comparison in the Current Update; Trading Move - vinanet.vn
Disc Medicine CEO John Quisel sells $2.6m in shares By Investing.com - Investing.com Australia
Disc Medicine CEO John Quisel sells $2.6m in shares - Investing.com
Disc Medicine CEO John D. Quisel disposes of USD 2.63 million in common shares - Bitget
Insider Selling: Disc Medicine (NASDAQ:IRON) CEO Sells 33,000 Shares of Stock - MarketBeat
Disc Medicine (IRON) CEO sells 33K shares under trading plan - Stock Titan
Disc Medicine Investor News: If You Have Suffered Losses in - GlobeNewswire
GSA Capital Partners LLP Takes $1.19 Million Position in Disc Medicine, Inc. $IRON - MarketBeat
Disc Medicine faces class action after FDA reje... - Pluang
Rosen Law Firm Encourages Disc Medicine, Inc. Investors to Inquire About Securities Class Action InvestigationIRON - PR Newswire
Disc Medicine (NASDAQ: IRON) insider to sell 33,000 shares via plan - Stock Titan
Disc Medicine (IRON) Pulls Back 1.46% to $78.84 as Shares Test Key Resistance ZoneExhaustion Gap - vinanet.vn
Disc Medicine (IRON) Slips 1.46% as Biotech Consolidates Near Key SupportCovered Call ETF - Vinanet
Disc Medicine COO Jonathan Yu sells $66,444 in shares By Investing.com - Investing.com Australia
Insider Selling: Disc Medicine (NASDAQ:IRON) COO Sells 804 Shares - MarketBeat
Disc Medicine COO Jonathan Yu sells $66,444 in shares - Investing.com
Disc Medicine (NASDAQ: IRON) COO trades 804 shares via 10b5-1 plan - Stock Titan
Disc Medicine Investor News: If You Have Suffered Losses in Disc Medicine, Inc. (NASDAQ: IRON), ... - Caledonian Record
Sei Investments Co. Takes Position in Disc Medicine, Inc. $IRON - MarketBeat
FMR LLC Trims Disc Medicine Inc (IRON) Stake: A Strategic Reduction Amid Biotech Volatility - GuruFocus
Disc Medicine, Inc. (IRON) Investor Outlook: Potential 29% Upside Ignites Interest - DirectorsTalk Interviews
Renaissance Technologies LLC Sells 31,000 Shares of Disc Medicine, Inc. $IRON - MarketBeat
Price-Driven Insight from (IRON) for Rule-Based Strategy - Stock Traders Daily
The Manufacturers Life Insurance Company Decreases Stock Position in Disc Medicine, Inc. $IRON - MarketBeat
Disc Medicine, Inc. $IRON Shares Sold by Assenagon Asset Management S.A. - MarketBeat
HC Wainwright Decreases Earnings Estimates for Disc Medicine - MarketBeat
Disc Medicine Inc (IRON) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Rahul Khara, Disc Medicine CLO, sells $400,000 in shares By Investing.com - Investing.com Australia
Disc Medicine Stock Slumps After FDA Declines Approval For Inherited Disorder Drug Over Efficacy Concerns - Stocktwits
Rahul Khara, Disc Medicine CLO, sells $400,000 in shares - Investing.com
Disc Medicine (NASDAQ:IRON) Insider Rahul Khara Sells 5,000 Shares - MarketBeat
Disc Medicine Chief Legal Officer Rahul Khara disposes of 5,000 common shares for $400,000 - Bitget
Disc Medicine Insider Sold Shares Worth $400,000, According to a Recent SEC Filing - Moomoo
Disc Medicine (NASDAQ: IRON) CLO sells 5,000 shares after option exercise - Stock Titan
FY2029 EPS Estimates for Disc Medicine Lowered by Analyst - marketbeat.com
IRON (IRON) filer plans 5,000-share stock sale after option exercise - Stock Titan
Disc Medicine (IRON): FMR LLC, Abigail Johnson report 12.8% ownership of common stock - Stock Titan
HC Wainwright Forecasts Strong Price Appreciation for Disc Medicine (NASDAQ:IRON) Stock - MarketBeat
IRON Maintained by HC Wainwright & Co. -- Price Target Raised to $120 - GuruFocus
H.C. Wainwright Maintains Disc Medicine(IRON.US) With Buy Rating, Announces Target Price $120 - Moomoo
Dimensional Fund Advisors LP Raises Holdings in Disc Medicine, Inc. $IRON - MarketBeat
Disc Medicine (IRON) Slips 1.86% as Biotech Stock Tests Key Support ZoneAnalyst Upgrade Stocks - vinanet.vn
Disc Medicine, Inc. Revenue Breakdown – NASDAQ:IRON - TradingView
Disc Medicine, Inc. (IRON) Stock Analysis: Exploring a 32% Potential Upside with Strong Buy Ratings - directorstalkinterviews.com
Lazard Asset Management LLC Lowers Stock Position in Disc Medicine, Inc. $IRON - MarketBeat
Disc Medicine, Inc. (NASDAQ:IRON) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
Bank of New York Mellon Corp Raises Holdings in Disc Medicine, Inc. $IRON - MarketBeat
How Investors Are Reacting To Disc Medicine (IRON) Balancing Larger Losses With APOLLO Phase 3 FDA Alignment - simplywall.st
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):